COVID-19 Drug Development: Role of Drug Repurposing
The COVID-19 pandemic came at a time when the scientific world was least prepared for it. It emerged at a time when there were variable research availability and limited mechanistic insights about the virus. Amid these challenges, research works were carried out in a bid to discover ways of curbing...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/84241 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | The COVID-19 pandemic came at a time when the scientific world was least prepared for it. It emerged at a time when there were variable research availability and limited mechanistic insights about the virus. Amid these challenges, research works were carried out in a bid to discover ways of curbing the spread of the virus and improving the health outcome of the population. Drug repurposing was one concept that was explored by scientists. Through this concept, already existing drugs were repurposed for the treatment of COVID-19, with incredible results seen. This chapter provides insights on some repurposed drugs, steps taken in drug repurposing, challenges peculiar to the methods, and a framework for continuity. |
|---|---|
| ISBN: | 978-1-80356-989-5 |
| DOI: | 10.5772/intechopen.107939 |